by XMRV Global Action on Saturday, January 15, 2011:
The virus is present in the most aggressive types of prostate cancer. Right now, we take a “watch and wait” attitude because we don’t know in which person the cancer will kill them, and in which the cancer will be controlled by the immune system.
But if this is a biomarker of the most aggressive cancer, then we can have a better treatment protocol and save millions of dollars in public health by not treating people who don’t need treatment as early, and really change the way we treat prostate cancer.
Association with CFS
… We have associated XMRV with a significant portion of the cohorts throughout America, and the group of Dr Lo and Alter at the FDA and NIH confirmed that on the East Coast.
There have been several groups also in Spain, Norway and Belgium where we have identified the virus, very high numbers of CFS. Read more>>